Clinical trial Recruiting at 1 site Observational Ages 1 Year to 18

Strategy to test risk of type 1 diabetes in kids with celiac disease

Official title: Celiac Autoimmunity and Risk Evaluation Strategies for Type 1 Diabetes in Pediatric Patients

Run by University of Bari · NCT07862101 · Data updated 2026-11-12

This study looks at how likely kids with celiac disease are to develop type 1 diabetes by gathering and analyzing health information from patients at the University of Bari.

More Diabete Type 2 trials

Quick facts

Study typeObservational
Ages1 Year to 18 Years
SexAll
Enrollment600 (estimated)
SponsorUniversity of Bari
Academic / other
Locations1 site (Bari, BA)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 7, 2026
Trial IDNCT07862101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1–18 with biopsy-confirmed celiac disease and no prior diagnosis of type 1 diabetes.

Probably not a fit

Children already diagnosed with type 1 diabetes or with other autoimmune endocrinopathies may not receive a direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses population-based data to explore the risk and timing of type 1 diabetes in pediatric patients with biopsy-confirmed celiac disease. It aims to identify how genetic and clinical factors relate to the co-occurrence of these autoimmune conditions. The investigation leverages existing clinical information to characterize the relationship between celiac disease and the development of type 1 diabetes, without an intervention. Results could inform screening strategies and follow-up planning for at-risk children. The study is centered at the University of Bari, focusing on pediatric patients seen in Bari, Italy.

Why it matters

Potential benefit: If successful, the study could help doctors identify which children with celiac disease are at higher risk for developing type 1 diabetes and tailor monitoring accordingly.

How similar studies have gone: Previous international work has shown overlaps in autoimmune risk, supporting the value of population-based screening approaches, though this specific combination in pediatric celiac patients is observational and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 1-18 years with biopsy-confirmed CD.
* Informed consent from parents/legal guardians and assent from the child (as applicable).

Exclusion Criteria:

* • Known diagnosis of type 1 diabetes.

  * Other autoimmune endocrinopathies or immunosuppressive therapy.

Where it's running

  • University Of Bari Aldo Moro-Pediatric Gastroenterology Section
    Bari, Ba, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.